YORVIPATH® (palopegteriparatide) is now registered by the Therapeutic Goods Administration (TGA) for the treatment of chronic ...

Septerna discontinues phase 1 clinical trial of SEP-786; plans to advance next-generation oral small molecule PTH1R agonist: South San Francisco, California Friday, February 21, 2 ...

There can be many symptoms of a faulty parathyroid, but my main symptom was that I was mean as a snake! I had the one ...

Dear Annie: I just read your column about the woman whose sister-in-law has become exceedingly short-tempered and abusive, ...

I happened to go for my annual physical and the blood test found high levels of calcium and parathyroid hormone. It happened ...

Menopause is a natural phase in a woman's life, but it often comes with health challenges, particularly when it comes to bone ...

During those vacations and other fun times, when we take group photos together, Adrienne only posts pictures of herself and ...

During those vacations and other fun times, when we take group photos together, Adrienne only posts pictures of herself and ...

I’ve told her how hurtful this feels to me and, potentially, my kids, now that they’re on social media. She assures me she ...

Septerna stood out from the crowd of biotech IPOs last year due to the lack of clinical data to hand. Now, the data are ...

Trial decision follows unanticipated events of elevated unconjugated bilirubin levels Company advancing multiple next-generation PTH1R agonists with distinct and unrelated chemical structures relative ...

Dear Cropped Out: Adrienne’s persistent exclusion of you and your kids on social media is certainly hurtful, and your feelings are valid. Social media doesn’t define a relationship, but in today’s ...